Trial · NCT07890740

Continuous Glucose Monitoring and Dietary Self-Management in Adults in Namwon

NCT07890740, Not applicable, Not yet recruiting, Ji-Yeob Choi

3 sourcestrials-2026-11-12-0.5.0

Cite this record

ConductScience Library. Continuous Glucose Monitoring and Dietary Self-Management in Adults in Namwon. Trials, record NCT07890740. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07890740

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title: Continuous Glucose Monitoring and Dietary Self-Management in Adults in Namwon
NCT number: NCT07890740
Status: Not yet recruiting
Phases: Not applicable
Enrollment: 860 participants, estimated
Lead sponsor: Ji-Yeob Choi
Conditions: Prediabetes, Dietary Self-Management, Diabetes Mellitus, Type 2
Interventions: Continuous Glucose Monitoring With Application-Based Biofeedback, Common Standardized Education and Behavioral Goal Setting, Common Digital Health Program and Basic Health Counseling
First posted: 2026-10-22
Last updated: 2026-10-22

Source ClinicalTrials.gov

Registered outcomes16

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

List	Outcome	Time frame	Description
Primary	Dietary Self-Management Score at Week 6	Week 6 after the actual randomization date (Day 0); assessment window: Days 35-49.	Study-specific mean of three adapted items: healthy eating, healthy eating plan adherence, and vegetable consumption. Items 1 and 3 recall the past 7 days; item 2 recalls average weekly practice over the past month. Items and mean range 0-7; higher scores indicate more frequent self-management. No reverse scoring. With one missing item, use the mean of two; with two or more missing, the score is missing. Compare week 6 scores with adjustment for the pre-allocation score on the randomization date, diabetes-status stratum, and enrollment location. If screening occurred earlier, repeat all four dietary items before allocation; use the first three for this baseline. This adapted score is not an unchanged validated scale. If ill in the most recent 7 days, use the preceding 7 days without illness for 7-day items.
Secondary	Average Weekly PASTA Application Login Days	From the actual randomization date (Day 0) through the week 6 assessment (Days 35-49).	Mean number of days per week with a login to the PASTA digital health application, from the actual randomization date (Day 0) through the week 6 assessment (range 0-7 days/week; higher values indicate more frequent use). Participants with confirmed non-installation or no use are assigned zero; records unavailable because of data transfer failure or withdrawn data permission are treated as missing. Glucose-linked functions are available only to the device group before week 6, which is considered when interpreting between-group differences.
Secondary	Body Weight at Week 6	Week 6 after the actual randomization date (Day 0); assessment window: Days 35-49.	Body weight in kilograms, measured at the study visit. The week 6 value is compared between randomized groups with adjustment for baseline body weight, diabetes-status stratum, and enrollment location. Baseline is the pre-allocation measurement from the first screening visit.
Secondary	Waist Circumference at Week 6	Week 6 after the actual randomization date (Day 0); assessment window: Days 35-49.	Waist circumference in centimeters, measured at the study visit. The week 6 value is compared between randomized groups with adjustment for baseline waist circumference, diabetes-status stratum, and enrollment location. Baseline is the pre-allocation measurement from the first screening visit.
Secondary	Systolic Blood Pressure at Week 6	Week 6 after the actual randomization date (Day 0); assessment window: Days 35-49.	Systolic blood pressure in millimeters of mercury, measured at the study visit. The week 6 value is compared between randomized groups with adjustment for baseline systolic blood pressure, diabetes-status stratum, and enrollment location. Baseline is the pre-allocation measurement from the first screening visit.
Secondary	Diastolic Blood Pressure at Week 6	Week 6 after the actual randomization date (Day 0); assessment window: Days 35-49.	Diastolic blood pressure in millimeters of mercury, measured at the study visit. The week 6 value is compared between randomized groups with adjustment for baseline diastolic blood pressure, diabetes-status stratum, and enrollment location. Baseline is the pre-allocation measurement from the first screening visit.
Other	Dietary Self-Management Score at Week 12	Week 12 after the actual randomization date (Day 0); assessment window: Days 77-91.	Mean of the same first three study-specific dietary self-care items used for the primary outcome, ranging from 0 to 7, with higher scores indicating more frequent dietary self-management. If one item is missing, the mean of the two available items is used; if two or more are missing, the score is missing. Exploratory follow-up after both groups have been offered a sensor. Results are described by original randomized group and do not represent a concurrent device-versus-no-device comparison; the primary controlled comparison ends at week 6.
Other	Body Weight at Week 12	Week 12 after the actual randomization date (Day 0); assessment window: Days 77-91.	Body weight in kilograms at the week 12 visit. Exploratory follow-up after both groups have been offered a sensor. Results are described by original randomized group and do not represent a concurrent device-versus-no-device comparison; the primary controlled comparison ends at week 6.
Other	Waist Circumference at Week 12	Week 12 after the actual randomization date (Day 0); assessment window: Days 77-91.	Waist circumference in centimeters at the week 12 visit. Exploratory follow-up after both groups have been offered a sensor. Results are described by original randomized group and do not represent a concurrent device-versus-no-device comparison; the primary controlled comparison ends at week 6.
Other	Systolic Blood Pressure at Week 12	Week 12 after the actual randomization date (Day 0); assessment window: Days 77-91.	Systolic blood pressure in millimeters of mercury at the week 12 visit. Exploratory follow-up after both groups have been offered a sensor. Results are described by original randomized group and do not represent a concurrent device-versus-no-device comparison; the primary controlled comparison ends at week 6.

1 to 10 of 16Source ClinicalTrials.gov

See all 16 registered outcomes

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov: 2026-11-12; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
NIH grant links: 2026-11-13; NIH RePORTER

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07890740

GET https://conductscience.org/api/trials/v1/NCT07890740/registered

API reference For AI assistants